BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 24973904)

  • 1. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
    Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
    Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
    Sothornwit J; Kaewrudee S; Lumbiganon P; Pattanittum P; Averbach SH
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD011913. PubMed ID: 36302159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
    Mark A; Sonalkar S; Borgatta L
    Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Gariepy AM; Duffy JY; Xu X
    Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of etonogestrel subdermal implant-related bleeding.
    Casey PM; Long ME; Drozdowicz LB; Marnach ML; Weaver AL
    J Reprod Med; 2014; 59(5-6):306-12. PubMed ID: 24937974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.
    Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF
    Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation.
    Obijuru L; Bumpus S; Auinger P; Baldwin CD
    J Adolesc Health; 2016 Mar; 58(3):284-9. PubMed ID: 26903428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate versus delayed postpartum insertion of contraceptive implant for contraception.
    Sothornwit J; Werawatakul Y; Kaewrudee S; Lumbiganon P; Laopaiboon M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011913. PubMed ID: 28432791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of body mass index with removal of etonogestrel subdermal implant.
    Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
    Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study.
    Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J
    Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users.
    Peterson AM; Brown A; Savage A; Dempsey A
    Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):475-479. PubMed ID: 31545110
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safety profile of etonogestrel contraceptive implant (Nexplanon
    Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
    Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
    Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.